Reverse-Switch Of Stada’s Lemocin On The Agenda Of Germany's Switch Committee
Executive Summary
Germany's Expert Committee for Prescription will consider the reverse-switch of tyrothricin – a key ingredient in Stada's recently-acquired Lemocin throat lozenge – to presciption-only status and the Rx-to-OTC switch of soluble fluoride tablets for the oral treatment of osteoporosis.